Energy metabolism in the hypothalamus and plasma cortisol levels in patients with schizophrenia.
Wik
G
G
Department of Clinical Neuroscience, Karolinska Hospital, Stockholm, Sweden.
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002746:Chlorpromazine / Q000009:adverse effects / Q000627:therapeutic use; D004734:Energy Metabolism / Q000502:physiology*; D005947:Glucose / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D007031:Hypothalamus / Q000378:metabolism*; D012559:Schizophrenia / Q000097:blood* / Q000188:drug therapy; D013469:Sulpiride / Q000009:adverse effects / Q000627:therapeutic use; D014055:Tomography, Emission-Computed
D014150:Antipsychotic Agents; D013469:Sulpiride; D005947:Glucose; D002746:Chlorpromazine; D006854:Hydrocortisone